@sunstonetherapies
Focused on research & gold standard delivery of psychedelic assisted therapies.
Survey: Help shape the future of care
Survey: Help shape the future of care
Take a short, anonymous survey on emotional well-being. Your experience can help shape new approaches to care.
Recent psilocybin group therapy research
Recent psilocybin group therapy research
Talk Therapy with Sunstone Therapists!
Talk Therapy with Sunstone Therapists!
Explore Talk Therapy with Sunstone Therapists, where your unique story is met with compassion, curiosity, and clinical expertise.
Podcast: Beyond the Diagnosis with Healing Cancer Journey
Podcast: Beyond the Diagnosis with Healing Cancer Journey
Why does modern cancer care excel at extending survival while often struggling to address theexistential suffering that defines so much of the cancer experie...
CYB003 Phase 3 Trial: Major Depressive Disorder
CYB003 Phase 3 Trial: Major Depressive Disorder
VLS-01-BU: Trial for Treatment Resistant Depression
VLS-01-BU: Trial for Treatment Resistant Depression
RE104 Study: Adjustment Disorder & Serious Illness
RE104 Study: Adjustment Disorder & Serious Illness
Sunstone's 2Dose Study: Psilocybin for Cancer Care
Sunstone's 2Dose Study: Psilocybin for Cancer Care
previous
next
Explore Enrolling Clinical Trials
Explore Enrolling Clinical Trials
Join the Sunstone Community and Stay Connected
Join the Sunstone Community and Stay Connected
Subscribe to Sunstone’s newsletter for the latest psychedelic therapy news. Get updates on MDMA, DMT and psilocybin trials and breakthroughs for PTSD & depression.
Play Video
Watch: Sunstone Psychedelic Studies Webinar
Discomfort and Emotional Wisdom with Psychedelic Therapy
Discomfort and Emotional Wisdom with Psychedelic Therapy
A psychedelic therapist’s perspective on the role of emotional wisdom and exploring rather than suppressing discomfort.
Sunstone's Research Highlighted in Oprah Daily
Sunstone's Research Highlighted in Oprah Daily
A new study suggests that a single dose of psilocybin can bring years of emotional relief.
Sunstone Published Research: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer
Sunstone Published Research: Long‐term benefits of single‐dose psilocybin in depressed patients with cancer
A phase 2 trial demonstrated safety, feasibility, and efficacy of a single 25-mg dose of psilocybin combined with psychological support in a community cancer setting in patients with cancer and a maj...
Podcast: Power to the Patient with CEO Dr. Manish Agrawal
Podcast: Power to the Patient with CEO Dr. Manish Agrawal
In this episode, Brandon Li sits down with Manish Agrawal, Co-Founder and CEO of Sunstone Therapies, to discuss the transformative role of psychedelics in ca...
The Paradox of Expectations in Psychedelic Clinical Research
The Paradox of Expectations in Psychedelic Clinical Research
Setting expectations in psychedelic therapy is crucial. Find out how it impacts safety and enhances the therapeutic experience.
Sunstone Published Research: Psilocybin Therapy & Cancer Care
Sunstone Published Research: Psilocybin Therapy & Cancer Care
New research shows Meaning-Centered Psychotherapy enhances psilocybin-assisted therapy, helping cancer patients with depression find meaning and relief.
Podcast: Perspectives on Psychedelic Research, Clinical Trials, and How We Can Continue To Connect With Heart | Living Medicine Institute
Podcast: Perspectives on Psychedelic Research, Clinical Trials, and How We Can Continue To Connect With Heart | Living Medicine Institute
On today’s episode of Living Medicine, Dr. Sandy Newes hosts Dr. Manish Agrawal, MD, the Co-founder and CEO of Sunstone Therapies, to discuss clinical trials in psychedelic therapy research. Dr. Agrawal talks about balancing the risks and benefits of psychedelic-assisted psychotherapy, his transition from oncology to psychedelic therapy, and the limitations of this groundbreaking research.
Pharmacy Times’ Four-Part Interview Series with Dr. Manish Agrawal on the Future of Psychedelic-Assisted Therapy in Oncology
Pharmacy Times’ Four-Part Interview Series with Dr. Manish Agrawal on the Future of Psychedelic-Assisted Therapy in Oncology
Explore insights into the future of psychedelic-assisted therapy in oncology and its growing acceptance in cancer care.
The Psychedelic Practitioner: Insights for Therapists
The Psychedelic Practitioner: Insights for Therapists
How to Treat Cancer in Its Entirety
How to Treat Cancer in Its Entirety
Can Psychedelic Therapy Help Veterans’ Mental health?
Can Psychedelic Therapy Help Veterans’ Mental health?
Healing the Invisible Wounds of War
Healing the Invisible Wounds of War
The Power of the Group in Psychedelic-Assisted Therapy
The Power of the Group in Psychedelic-Assisted Therapy
New Frontiers in Military Mental Health Science and Practice: Catalyzing Therapy with Psychedelics
New Frontiers in Military Mental Health Science and Practice: Catalyzing Therapy with Psychedelics
The Epidemiology of Psychedelic Use Among United States Military Veterans
The Epidemiology of Psychedelic Use Among United States Military Veterans
Curing cancer's mental toll
Curing cancer's mental toll
Letter from Sunstone CEO, Manish Agrawal MD
Letter from Sunstone CEO, Manish Agrawal MD
Podcast: Soul of Life - How Sunstone Therapies is Opening Doors to Psychedelic Treatment
Podcast: Soul of Life - How Sunstone Therapies is Opening Doors to Psychedelic Treatment
Podcast: Security HALT! - Eloise Cherian Healing Trauma with Psychedelic-Assisted Therapy
Podcast: Security HALT! - Eloise Cherian Healing Trauma with Psychedelic-Assisted Therapy
Psychedelics: Subjectivity in the Therapeutic Response
Psychedelics: Subjectivity in the Therapeutic Response
Explore Open Positions
Explore Open Positions
Instagram
Instagram
X
X
Facebook
Facebook
LinkedIn
LinkedIn
View on mobile